3g0u
From Proteopedia
m (Protected "3g0u" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | [[Image:3g0u.png|left|200px]] | ||
- | |||
{{STRUCTURE_3g0u| PDB=3g0u | SCENE= }} | {{STRUCTURE_3g0u| PDB=3g0u | SCENE= }} | ||
- | |||
===Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 4=== | ===Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 4=== | ||
+ | {{ABSTRACT_PUBMED_19351152}} | ||
- | + | ==Disease== | |
+ | [[http://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN]] Defects in DHODH are the cause of postaxial acrofacial dysostosis (POADS) [MIM:[http://omim.org/entry/263750 263750]]; also known as Miller syndrome. POADS is characterized by severe micrognathia, cleft lip and/or palate, hypoplasia or aplasia of the posterior elements of the limbs, coloboma of the eyelids and supernumerary nipples. POADS is a very rare disorder: only 2 multiplex families, each consisting of 2 affected siblings born to unaffected, nonconsanguineous parents, have been described among a total of around 30 reported cases.<ref>PMID:19915526</ref> | ||
+ | |||
+ | ==Function== | ||
+ | [[http://www.uniprot.org/uniprot/PYRD_HUMAN PYRD_HUMAN]] Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor. | ||
==About this Structure== | ==About this Structure== | ||
Line 11: | Line 13: | ||
==Reference== | ==Reference== | ||
- | <ref group="xtra">PMID:019351152</ref><references group="xtra"/> | + | <ref group="xtra">PMID:019351152</ref><references group="xtra"/><references/> |
[[Category: Dihydroorotate oxidase]] | [[Category: Dihydroorotate oxidase]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] |
Revision as of 03:05, 25 March 2013
Contents |
Human dihydroorotate dehydrogenase in complex with a leflunomide derivative inhibitor 4
Template:ABSTRACT PUBMED 19351152
Disease
[PYRD_HUMAN] Defects in DHODH are the cause of postaxial acrofacial dysostosis (POADS) [MIM:263750]; also known as Miller syndrome. POADS is characterized by severe micrognathia, cleft lip and/or palate, hypoplasia or aplasia of the posterior elements of the limbs, coloboma of the eyelids and supernumerary nipples. POADS is a very rare disorder: only 2 multiplex families, each consisting of 2 affected siblings born to unaffected, nonconsanguineous parents, have been described among a total of around 30 reported cases.[1]
Function
[PYRD_HUMAN] Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.
About this Structure
3g0u is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Davies M, Heikkila T, McConkey GA, Fishwick CW, Parsons MR, Johnson AP. Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases. J Med Chem. 2009 May 14;52(9):2683-93. PMID:19351152 doi:10.1021/jm800963t
- ↑ Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, Huff CD, Shannon PT, Jabs EW, Nickerson DA, Shendure J, Bamshad MJ. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet. 2010 Jan;42(1):30-5. doi: 10.1038/ng.499. Epub 2009 Nov 13. PMID:19915526 doi:10.1038/ng.499
Categories: Dihydroorotate oxidase | Homo sapiens | Davis, M. | Fishwick, C W.G. | Heikkila, T. | Johnson, A P. | McConkey, G A. | Parsons, M R. | Beta-alpha-barrel | Fad | Flavoprotein | Membrane | Mitochondrion | Mitochondrion inner membrane | Oxidoreductase | Pyrimidine biosynthesis | Tim-barrel | Transit peptide